Conmed (CNMD) Other Accumulated Expenses (2010 - 2026)

Conmed (CNMD) has 17 years of Other Accumulated Expenses data on file, last reported at $106.8 million in Q2 2026.

• Quarterly Other Accumulated Expenses fell 14.67% year-over-year to $106.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $106.8 million (down 14.67% YoY) and the FY2025 annual result came in at $138.5 million, up 26.18% from the prior year.
• Other Accumulated Expenses retreated to $106.8 million in Q2 2026, from $125.7 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $163.5 million in Q3 2023 to a low of $62.5 million in Q1 2022.
• A 5-year average of $118.7 million and a median of $125.0 million in 2023 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2023 — Other Accumulated Expenses surged 104.31% — and 2024, when it dropped 29.29%.
• Tracing CNMD's Other Accumulated Expenses over 5 years: stood at $98.7 million in 2022, then surged by 53.76% to $151.7 million in 2023, then retreated by 27.63% to $109.8 million in 2024, then rose by 26.18% to $138.5 million in 2025, then decreased by 22.94% to $106.8 million in 2026.
• The last three Other Accumulated Expenses figures came in at $106.8 million (Q2 2026), $125.7 million (Q1 2026), and $138.5 million (Q4 2025), per Business Quant data.